These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29152503)

  • 1. Nomogram for survival analysis in the presence of competing risks.
    Zhang Z; Geskus RB; Kattan MW; Zhang H; Liu T
    Ann Transl Med; 2017 Oct; 5(20):403. PubMed ID: 29152503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis in the presence of competing risks.
    Zhang Z
    Ann Transl Med; 2017 Feb; 5(3):47. PubMed ID: 28251126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model.
    Austin PC; Latouche A; Fine JP
    Stat Med; 2020 Jan; 39(2):103-113. PubMed ID: 31660633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
    Austin PC; Steyerberg EW; Putter H
    Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
    Austin PC; Fine JP
    Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified.
    Grambauer N; Schumacher M; Beyersmann J
    Stat Med; 2010 Mar; 29(7-8):875-84. PubMed ID: 20213713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression.
    Kohl M; Plischke M; Leffondré K; Heinze G
    Comput Methods Programs Biomed; 2015 Feb; 118(2):218-33. PubMed ID: 25572709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the relation between the cause-specific hazard and the subdistribution rate for competing risks data: The Fine-Gray model revisited.
    Putter H; Schumacher M; van Houwelingen HC
    Biom J; 2020 May; 62(3):790-807. PubMed ID: 32128860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data.
    He P; Eriksson F; Scheike TH; Zhang MJ
    Scand Stat Theory Appl; 2016 Mar; 43(1):103-122. PubMed ID: 27034534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
    Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
    J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive subdistribution hazards regression for competing risks data in case-cohort studies.
    Wogu AF; Li H; Zhao S; Nichols HB; Cai J
    Biometrics; 2023 Dec; 79(4):3010-3022. PubMed ID: 36606409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric competing risks regression under interval censoring using the R package intccr.
    Park J; Bakoyannis G; Yiannoutsos CT
    Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
    Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
    Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the Risk Factors Affecting on Death Due to Colorectal Cancer Progression: Survival Analysis in the Presence of Competing Risks.
    Safari M; Mahjub H; Esmaeili H; Abbasi M; Roshanaei G
    J Gastrointest Cancer; 2022 Jun; 53(2):348-355. PubMed ID: 33656691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models.
    Austin PC; Putter H; Lee DS; Steyerberg EW
    Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008368. PubMed ID: 35098725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.
    Cantagallo E; De Backer M; Kicinski M; Ozenne B; Collette L; Legrand C; Buyse M; Péron J
    Biom J; 2021 Feb; 63(2):272-288. PubMed ID: 32939818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
    Beyersmann J; Schumacher M
    Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.